CN101890152A - 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 - Google Patents
山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 Download PDFInfo
- Publication number
- CN101890152A CN101890152A CN2010101715338A CN201010171533A CN101890152A CN 101890152 A CN101890152 A CN 101890152A CN 2010101715338 A CN2010101715338 A CN 2010101715338A CN 201010171533 A CN201010171533 A CN 201010171533A CN 101890152 A CN101890152 A CN 101890152A
- Authority
- CN
- China
- Prior art keywords
- glucoprotein
- brown
- chinese potato
- chinese yam
- potato glucoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000002722 Dioscorea batatas Nutrition 0.000 title claims abstract description 45
- 239000003814 drug Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 7
- 102000003886 Glycoproteins Human genes 0.000 title abstract description 4
- 108090000288 Glycoproteins Proteins 0.000 title abstract description 4
- 235000006536 Dioscorea esculenta Nutrition 0.000 title abstract 7
- 240000001811 Dioscorea oppositifolia Species 0.000 title abstract 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 title abstract 7
- 230000000141 anti-hypoxic effect Effects 0.000 title abstract 3
- 241000234272 Dioscoreaceae Species 0.000 claims abstract description 11
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims abstract description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims abstract description 7
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 6
- 150000004676 glycans Chemical class 0.000 claims abstract description 6
- 239000004475 Arginine Substances 0.000 claims abstract description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 4
- 239000004471 Glycine Substances 0.000 claims abstract description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims abstract description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000004472 Lysine Substances 0.000 claims abstract description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229940024606 amino acid Drugs 0.000 claims abstract description 4
- 150000001413 amino acids Chemical class 0.000 claims abstract description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 4
- 229930182830 galactose Natural products 0.000 claims abstract description 4
- 239000008103 glucose Substances 0.000 claims abstract description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960000310 isoleucine Drugs 0.000 claims abstract description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 4
- 239000005017 polysaccharide Substances 0.000 claims abstract description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000004474 valine Substances 0.000 claims abstract description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 3
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 claims description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- 235000005602 Coleus parviflorus Nutrition 0.000 claims description 38
- 206010021143 Hypoxia Diseases 0.000 claims description 16
- 239000006228 supernatant Substances 0.000 claims description 15
- 229920000297 Rayon Polymers 0.000 claims description 11
- 239000003292 glue Substances 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 102000011759 adducin Human genes 0.000 claims description 5
- 108010076723 adducin Proteins 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 241001529246 Platymiscium Species 0.000 claims description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 235000009697 arginine Nutrition 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 235000014304 histidine Nutrition 0.000 claims description 3
- 235000018977 lysine Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- 238000000151 deposition Methods 0.000 claims description 2
- 230000008021 deposition Effects 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- 235000006109 methionine Nutrition 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 150000004804 polysaccharides Polymers 0.000 claims description 2
- 238000000247 postprecipitation Methods 0.000 claims description 2
- 235000013930 proline Nutrition 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 235000004400 serine Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 235000008521 threonine Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 238000002474 experimental method Methods 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract description 3
- 230000017854 proteolysis Effects 0.000 abstract description 2
- 241000234273 Dioscorea Species 0.000 abstract 1
- 235000005903 Dioscorea Nutrition 0.000 abstract 1
- 235000000504 Dioscorea villosa Nutrition 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 229920000715 Mucilage Polymers 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 229940009098 aspartate Drugs 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 229960002737 fructose Drugs 0.000 abstract 1
- 206010002660 Anoxia Diseases 0.000 description 9
- 241000976983 Anoxia Species 0.000 description 8
- 230000007953 anoxia Effects 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010171533 CN101890152B (zh) | 2010-05-13 | 2010-05-13 | 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010171533 CN101890152B (zh) | 2010-05-13 | 2010-05-13 | 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101890152A true CN101890152A (zh) | 2010-11-24 |
CN101890152B CN101890152B (zh) | 2012-12-05 |
Family
ID=43099610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010171533 Expired - Fee Related CN101890152B (zh) | 2010-05-13 | 2010-05-13 | 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101890152B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102920998A (zh) * | 2012-12-05 | 2013-02-13 | 多力坤·马木特 | 山药糖蛋白在提高脑细胞线粒体氧化代谢酶活性的用途 |
CN102920999A (zh) * | 2012-12-05 | 2013-02-13 | 多力坤·马木特 | 山药糖蛋白在制备治疗肾炎及肾性高血压的药物中的用途 |
CN102920991A (zh) * | 2012-12-05 | 2013-02-13 | 多力坤·马木特 | 山药多糖和山药蛋白质的组合物的用途 |
CN104004079A (zh) * | 2014-06-17 | 2014-08-27 | 黄香利 | 一种紫色淮山药粘液蛋白的提取方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101317622A (zh) * | 2008-03-25 | 2008-12-10 | 江苏大学 | 一种山药糖蛋白产品及其超声辅助提取的方法 |
CN101575367A (zh) * | 2009-05-26 | 2009-11-11 | 上海应用技术学院 | 一种山药糖蛋白及其制备方法 |
-
2010
- 2010-05-13 CN CN 201010171533 patent/CN101890152B/zh not_active Expired - Fee Related
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102920998A (zh) * | 2012-12-05 | 2013-02-13 | 多力坤·马木特 | 山药糖蛋白在提高脑细胞线粒体氧化代谢酶活性的用途 |
CN102920999A (zh) * | 2012-12-05 | 2013-02-13 | 多力坤·马木特 | 山药糖蛋白在制备治疗肾炎及肾性高血压的药物中的用途 |
CN102920991A (zh) * | 2012-12-05 | 2013-02-13 | 多力坤·马木特 | 山药多糖和山药蛋白质的组合物的用途 |
CN102920999B (zh) * | 2012-12-05 | 2013-10-30 | 多力坤·马木特 | 山药糖蛋白在制备治疗肾炎及肾性高血压的药物中的用途 |
CN102920998B (zh) * | 2012-12-05 | 2013-12-25 | 多力坤·马木特 | 山药糖蛋白在提高脑细胞线粒体氧化代谢酶活性的用途 |
CN102920991B (zh) * | 2012-12-05 | 2014-05-07 | 多力坤·马木特 | 山药多糖和山药蛋白质的组合物的用途 |
WO2014086257A1 (zh) * | 2012-12-05 | 2014-06-12 | Mamute Duolikun | 山药糖蛋白在制备治疗肾炎及肾性高血压的药物中的用途 |
WO2014086258A1 (zh) * | 2012-12-05 | 2014-06-12 | Mamute Duolikun | 山药糖蛋白提高脑细胞线粒体氧化代谢酶活性的用途 |
US20150315233A1 (en) * | 2012-12-05 | 2015-11-05 | Duolikun MAMUTE | Use of yam glycoprotein for improving activity of mitochondrial oxidative metabolic enzyme of brain cell |
EP2929889A4 (en) * | 2012-12-05 | 2016-08-31 | Duolikun Mamute | USE OF YAM GLYCOPROTEIN TO ENHANCE THE ACTIVITY OF THE MITOCHONDRIAL OXIDATIVE METABOLIC ENZYME OF A BRAIN CELL |
CN104004079A (zh) * | 2014-06-17 | 2014-08-27 | 黄香利 | 一种紫色淮山药粘液蛋白的提取方法 |
CN104004079B (zh) * | 2014-06-17 | 2016-08-24 | 黄香利 | 一种紫色淮山药粘液蛋白的提取方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101890152B (zh) | 2012-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101342317A (zh) | 一种治疗肺结核的药物组合物及其制备方法 | |
CN104623201B (zh) | 一种保肝排毒降脂降糖药物及其应用 | |
CN101890152B (zh) | 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 | |
KR20160064966A (ko) | 화학요법제 보조에 사용하는 의약 조성물 및 그 용도 | |
CN101822818B (zh) | 山药多糖和山药蛋白质组合物及其用途 | |
CN103191214B (zh) | 一种解酒护肝制剂 | |
CN101933963A (zh) | 一种治疗头痛的鼻用原位凝胶剂 | |
CN103948021A (zh) | 一种滁菊明目保健颗粒剂及其生产方法 | |
CN113101352A (zh) | 复方紫杉醇抗结核病胶囊药片制作方法及工艺 | |
CN112826917A (zh) | 一种复方桑葚黄芪中药组合物及其应用 | |
CN102631492B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN102078600A (zh) | 抗癌复方灵芝组合物、其用途和包含其的药物组合物 | |
CN101559166A (zh) | 一种麦冬提取物及其制备方法与降糖应用 | |
CN105688146A (zh) | 一种提高睡眠质量的保健胶囊 | |
CN104622912A (zh) | 一种无美洲大蠊异味的药物组合物 | |
CN109432390A (zh) | 一种用于鸡传染性喉气管炎的中药肽、药物及其制备方法 | |
CN113332314B (zh) | 一种牡蛎壳肉酶解物及其在制备治疗抑郁症的药物中的应用 | |
CN116531426B (zh) | 用于防治化疗所致白细胞减少的含硫普罗宁的药物组合物及其制备方法 | |
CN114470147B (zh) | 沙棘籽粕蛋白肽在制备解酒产品中的应用 | |
CN102861198A (zh) | 一种治疗肝硬化腹水的纯中药制剂 | |
CN102631506B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN102631486B (zh) | 一种保健组合物 | |
CN101015680B (zh) | F-苷肽在制备治疗肿瘤的药物中的应用 | |
CN102949681A (zh) | 一种预防或治疗感冒的组合物及其制备方法 | |
CN102631487B (zh) | 提高免疫力、抗疲劳的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: KASHI AIWEIMATE UYGUR PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: MAMUTE DUOLIKUN Effective date: 20140605 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 830002 URUMQI, XINJIANG UYGUR AUTONOMOUS REGION TO: 844000 KASHGAR, XINJIANG UYGUR AUTONOMOUS REGION |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140605 Address after: 844000, Yingbin Road, the Xinjiang Uygur Autonomous Region, Kashi, No. 288 Patentee after: Kashi alamart Uygur Pharmaceutical Co.,Ltd. Address before: 830002 No. 496 Xinhua South Road, the Xinjiang Uygur Autonomous Region, Urumqi Patentee before: Duolikun.Mamute |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121205 Termination date: 20190513 |
|
RR01 | Reinstatement of patent right | ||
RR01 | Reinstatement of patent right |
Former decision: termination of patent right due to unpaid annual fee Former decision publication date: 20200501 |
|
RR01 | Reinstatement of patent right | ||
RR01 | Reinstatement of patent right |
Former decision: Termination of patent right without annual fee Former decision publication date: 20200501 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121205 |